ABG

Ally Bridge Group Portfolio holdings

AUM $114M
This Quarter Return
+6.6%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$117M
AUM Growth
+$117M
Cap. Flow
-$66.8M
Cap. Flow %
-57.25%
Top 10 Hldgs %
55.08%
Holding
38
New
9
Increased
1
Reduced
19
Closed
8

Top Buys

1
ITCI
Intra-Cellular Therapies Inc.
ITCI
$12.3M
2
AXSM icon
Axsome Therapeutics
AXSM
$5.64M
3
SLNO icon
Soleno Therapeutics
SLNO
$3.94M
4
KRRO icon
Korro Bio
KRRO
$2.69M
5
EYPT icon
EyePoint Pharmaceuticals
EYPT
$2.59M

Top Sells

1
SRPT icon
Sarepta Therapeutics
SRPT
$8.99M
2
TARS icon
Tarsus Pharmaceuticals
TARS
$8.24M
3
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$8.03M
4
RVMD icon
Revolution Medicines
RVMD
$7.41M
5
SWTX
SpringWorks Therapeutics
SWTX
$6.25M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EWTX icon
26
Edgewise Therapeutics
EWTX
$1.54B
$2.22M 1.9%
83,176
-104,519
-56% -$2.79M
SWTX
27
DELISTED
SpringWorks Therapeutics
SWTX
$1.98M 1.69%
54,692
-173,008
-76% -$6.25M
CNTX icon
28
Context Therapeutics
CNTX
$75.6M
$1.66M 1.42%
1,576,762
-180,762
-10% -$190K
PMN icon
29
ProMIS Neurosciences
PMN
$23.7M
$1.51M 1.29%
1,592,605
– –
CLYM
30
Climb Bio, Inc. Common Stock
CLYM
$165M
$1.37M 1.17%
760,225
-469,067
-38% -$844K
LBPH
31
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
– –
-240,892
Closed -$8.03M
SRPT icon
32
Sarepta Therapeutics
SRPT
$1.98B
– –
-72,000
Closed -$8.99M
RVMD icon
33
Revolution Medicines
RVMD
$7.43B
– –
-163,500
Closed -$7.41M
RLAY icon
34
Relay Therapeutics
RLAY
$709M
– –
-626,058
Closed -$4.43M
KURA icon
35
Kura Oncology
KURA
$732M
– –
-294,081
Closed -$5.75M
IRON icon
36
Disc Medicine
IRON
$2.14B
– –
-100,000
Closed -$4.91M
CATX icon
37
Perspective Therapeutics
CATX
$251M
– –
-341,739
Closed -$4.56M
APLT icon
38
Applied Therapeutics
APLT
$73.7M
– –
-618,332
Closed -$5.26M
1
2